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Abstract
Background
Cigarette smoking by pregnant women is associated with a significant increase in the risk
for cognitive disorders in their children. Preclinical models confirm this risk by showing that
exposure of the developing brain to nicotine produces adverse behavioral outcomes. Here
we describe behavioral phenotypes resulting from perinatal nicotine exposure in a mouse
model, and discuss our findings in the context of findings from previously published studies
using preclinical models of developmental nicotine exposure.
Methodology/Principal findings
Female C57Bl/6 mice received drinking water containing nicotine (100μg/ml) + saccharin
(2%) starting 3 weeks prior to breeding and continuing throughout pregnancy, and until 3
weeks postpartum. Over the same period, female mice in two control groups received drink-
ing water containing saccharin (2%) or plain drinking water. Offspring from each group were
weaned at 3-weeks of age and subjected to behavioral analyses at 3 months of age. We
examined spontaneous locomotor activity, anxiety-like behavior, spatial working memory,
object based attention, recognition memory and impulsive-like behavior. We found signifi-
cant deficits in attention and working memory only in male mice, and no significant changes
in the other behavioral phenotypes in male or female mice. Exposure to saccharin alone did
not produce significant changes in either sex.
Conclusion/Significance
The perinatal nicotine exposure produced significant deficits in attention and working mem-
ory in a sex-dependent manner in that the male but not female offspring displayed these
behaviors. These behavioral phenotypes are associated with attention deficit hyperactivity
disorder (ADHD) and have been reported in other studies that used pre- or perinatal nicotine
exposure. Therefore, we suggest that preclinical models of developmental nicotine expo-
sure could be useful tools for modeling ADHD and related disorders.
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Introduction
It is estimated that approximately 37 million American adults and 3 million American middle
school and high school students smoke cigarettes [1]. In addition, the use of electronic ciga-
rettes (vaporized nicotine) is increasing, especially among young adults of reproductive age,
due to false perceptions of increased safety. Between 2013 and 2014, in just one year, the use of
e-cigarettes tripled among high school students [2]. Preclinical studies [3–9] and clinical stud-
ies [10–14] show that prenatal nicotine exposure or cigarette smoking by pregnant women is
associated with an increased risk of cognitive disabilities in their children. Moreover, the
adverse effects of nicotine exposure may not be limited to the nicotine exposed individuals
alone but may be evident in up to two subsequent generations descending from the prenatally
nicotine exposed individuals [8]. Therefore, the population at risk for the effects of prenatal
nicotine exposure may be much larger than previously recognized. Thus, understanding the
adverse effects of prenatal nicotine exposure, whether via conventional cigarettes, e-cigarettes
or smokeless tobacco is a highly significant public health issue.
Preclinical models of developmental nicotine exposure have advanced our knowledge of
the adverse effects of nicotine on the developing brain. However, variability in preclinical
experimental design has led to inconsistent findings. For example, the nicotine formulation,
route of nicotine administration, timing of nicotine exposure with respect to the stage of brain
development, as well as the types of behavioral tests performed vary significantly among the
different studies, even when the same species of experimental animals are used.
In fact, nicotine exposure can have different effects on the developing brain at different
stages of brain development, and each developmental stage may be uniquely vulnerable. Our
earlier studies [8, 9, 15] used a mouse model of prenatal nicotine exposure, in which the nico-
tine exposure began prior to conception and lasted until the day of birth. The prenatal period
in mice corresponds approximately to the first two trimesters of human pregnancy with
respect to brain development [16–19]. In the present study we extended the nicotine exposure
period to 3 weeks postpartum, so the exposure occurred over a period corresponding approxi-
mately to the entire human gestation period [16–19].
Our data show that perinatal nicotine exposure produces some but not all of the cognitive
phenotypes reported in our previous studies using prenatal nicotine exposure. When the pres-
ent findings are examined in the context of findings from the studies in the literature, attention
and working memory deficits emerge as the most consistent behavioral deficits associated with
preclinical models of developmental nicotine exposure.
Materials and methods
Animals
C57BL/6 mice were purchased from Charles River Laboratories (Kingston, NY) and housed in
the Florida State University laboratory animal care facility. The facility is a temperature and
humidity controlled environment maintained on a 12-hr light-dark cycle (lights off at 7 AM
and on at 7 PM) with food and water available ad libitum. Breeding age (8–12 week-old)
female mice were randomly assigned to one of three experimental groups based on the type of
drinking water supplied: nicotine + saccharin (N + S), saccharin only (S) or plain drinking
water (W). The mice in the N + S group were provided with drinking water containing100 μg/
ml nicotine ((-)-Nicotine, Sigma Chemical Company, St. Louis, MO; Cat# N3876) and 2% sac-
charin (Alfa Aesar, Heysham, England; Cat# A15530). Saccharin is used as a sweetener to
mask the bitter taste of nicotine in the drinking water [8, 9, 15]. The mice in the S group
received drinking water containing 2% saccharin, and the mice in the W group received
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drinking water without any additive. Following 3 weeks of such exposures, the female mice in
each experimental group were bred with drug naïve male mice. The day of successful mating
(verified by the detection of a vaginal plug) was designated embryonic day 0 (E0). Throughout
pregnancy each female mouse was single housed. The three types of drinking water exposures
continued until postnatal day (P) 21 when the offspring were weaned. To clarify, during the
postnatal period (P0 to P21), the offspring were exposed to saccharin and nicotine via mothers’
breast milk. Some offspring may have consumed the drinking water directly from the water
bottle, especially in the third postnatal week when they could have had direct access to the
water bottles. The litter size was standardized to contain 6–8 offspring on the day of birth.
All of the experimental procedures were in full compliance with institutional guidelines at
the Florida State University and the NIH Guide for the Care and Use of Laboratory Animals.
Behavioral analyses
The behavioral analyses began when the mice reached postnatal day (P) 90. The offspring of
the same sex from each of the three perinatal exposure groups were housed 2–4 per cage and
were handled by the experimenter for 5 min/day for 3 days prior to the beginning of the behav-
ioral analyses. Mice were habituated to the testing room for 30 min before the analyses com-
menced. The handling, habituation and behavioral testing occurred during the lights-off
period, under dim lighting.
Spontaneous locomotor activity
On the day of analysis, the mice were removed from their home cages, and placed individually
in testing cages equipped with Photobeam motion sensors (Photobeam Activity System; San
Diego Instruments). Each instance of consecutive break in adjacent photobeams (positioned
5.4 cm apart) was scored as an ambulatory event or activity. We analyzed activity during a 12
hr period from 19:00 hr to 7:00 hr (Fig 1), during the dark phase of the light-dark cycle.
Spatial working memory
Spatial working memory was assayed using a custom-built clear Plexiglas Y-maze consisting of
three arms (each arm was 35 cm long x 6 cm wide x 10 cm high) of equal dimensions arranged
in the shape of the letter “Y”. Unique visual cues were placed on the exterior of the walls of
each arm as well as on the walls of the testing room to facilitate recognition of each arm as
unique by the mouse. The mouse was placed at the center of the Y-maze, allowing free access
to all 3 arms, and its behavior was recorded over a 10-min period using an overhead video
camera. An investigator blinded to the identity of the mouse analyzed the video recordings to
calculate the number of entries into each arm and the sequence of arm entries (for this purpose
the arms were labeled A, B and C). An arm entry is considered to have occurred when all four
limbs of the mouse enter an arm. A “spontaneous alternation” is defined as a set of three con-
secutive arm choices without a repeated entry (e.g. ABC, BCA, CAB) (Fig 2). A spontaneous
alternation score was calculated using the formula: number of alternations / (number of
entries—2) X 100.
Elevated plus maze (EPM)
Anxiety-like behavior was analyzed using a standard mouse elevated plus maze (Med Associ-
ates, Inc., St. Albans, VT). The maze consisted of two open (50 cm × 10 cm) and two closed
arms (50 cm × 10 cm with 40 cm walls) opposing each other, arranged in the shape of a plus
sign (+). The behavioral task was initiated by placing the mouse at the center of the maze
Perinatal nicotine exposure mouse model
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facing one of the open arms with free access to the entire maze. Behavior was monitored via an
overhead camera for a 5 min period. The time spent in the open arms and the closed arms,
and the number of entries into open arms of maze were calculated from the video recordings.
Object based attention (OBA)
The OBA test has been used as a test of attention in mouse models [4, 15, 20]. A rectangular
Plexiglas box consisting of an exploration chamber (40 X 40 X 25 cm) and a testing chamber
(40 X 20 X 25 cm) separated by a sliding door was used. The analysis began with a handling
phase, in which the experimenter handled the mice 5 min/day for 3 days. On day 4, during the
habituation phase, the mouse was placed in the empty exploration chamber for 5 min and
then in the empty test chamber for another 5 min. The transit from the exploration chamber
to the test chamber was permitted by lifting the sliding door. If a mouse did not voluntarily
enter the test chamber, it was gently guided to do so. On day 5, during the acquisition session,
the mouse was placed for 5 min in the exploration chamber containing five wooden objects of
identical size but different shapes (rectangle, triangle, circle, oval and octagon). Next, the
mouse was placed in the test chamber containing two wooden objects of the same size and
shape (circle) for 5 min. The exploratory activity (defined as interactions with the object(s)
from a distance of not greater than 1.5 cm) was recorded in each chamber. On day 6, the
mouse was placed in the empty exploration chamber first and then in the empty test chamber,
for 3 min each to permit habituation to the chambers. Next the mouse was returned to the
exploration chamber, which now contained the same five objects that the mouse had explored
on day 5. The exploratory activity was recorded for 3 min. Next the sliding door was opened
and the mouse entered the test chamber, which now contained two objects. One object was of
the same shape and size as one of the five objects the mouse had explored 3 min earlier in the
Fig 1. Perinatal nicotine exposure and spontaneous locomotor activity. Cumulative spontaneous locomotor activity was analyzed during the lights-off period
(19:00–07:00 h) in male and female mice from the nicotine+saccharin (N + S), saccharin alone (S) and plain drinking water (W) groups. There was no significant
difference in this measurement among the three experimental groups. [Mean ± SEM: Male; W = 9148 ± 1722; S = 9009 ± 1862; N + S = 9410 ± 1862; Female:
W = 9172 ± 2048; S = 11284 ± 1783; N + S = 12394 ± 1983].
https://doi.org/10.1371/journal.pone.0198064.g001
Perinatal nicotine exposure mouse model
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Fig 2. Perinatal nicotine exposure and anxiety-like phenotype in elevated plus maze (EPM). The percentage of time spent in the
open versus closed arms (A) and the number of entries into open arms (B) of the EPM were analyzed. Neither measure showed
significant difference in male or female mice from the nicotine+saccharin (N + S), saccharin alone (S) and plain drinking water (W)
groups. [Mean ± SEM % time spent in open arms: Male: W = 26.44 ± 4.34; S = 23.89 ± 2.88; N + S = 23.56 ± 2.56; Female:
W = 17.65 ± 3.88; S = 19.05 ± 23.84; N + S = 21.53 ± 3.64. Mean ± SEM number of entries into open arms: Male: W = 9.67 ± 1.21;
S = 9.33 ± 1.17; N + S = 9.5 ± 1.16; Female: W = 8.40 ± 1.32; S = 8.20 ± 1.33; N + S = 8.00 ± 1.20].
https://doi.org/10.1371/journal.pone.0198064.g002
Perinatal nicotine exposure mouse model
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exploration chamber (familiar object), and placed in the test chamber in a position analogous
to its position of the object of the same shape in the exploration chamber. The second object
was a star shaped “novel” object which it has not previously encountered before. Although the
mouse had not been exposed to either of these two objects, it had been exposed to an object of
the same size and shape as the “familiar” object, but had never been exposed to the “novel”
object or any other star shaped object previously. The mouse explored the two objects for 3
min, and exploratory activity was recorded.
Preliminary analyses showed that the mice explored all four corners of the exploration and
test chambers equally. Therefore, on days 5 and 6, the two objects were placed in the test cham-
ber equidistant from the middle of the sliding door. The position of the objects in the explora-
tion and test chambers was fixed throughout the entire study. The familiar object was always a
circle and the novel object a star throughout the entire study.
The day 5 data were used to evaluate inclusion/exclusion criteria. Since all mice met the
inclusion criterion of exploring all objects in the exploration and test chambers on day 5, we
did not have to exclude any mouse from the study. Initial analysis revealed that the time spent
exploring the 5 objects by the mice in the three treatment groups was not significantly differ-
ent. During the test session, an exclusion criterion of<10% (i.e. < 18 s with both objects) was
used based on our own previous studies and data from other studies [3, 4, 15]. All mice met
this criterion, and therefore no mouse was excluded.
A recognition index was calculated using the formula: TN / (TF + TN) X 100, where TF and
TN are time spent during the test session exploring the familiar and the novel objects, respec-
tively, by an investigator blinded to the identity of the mouse.
Novel object recognition (NOR)
We used the NOR test to evaluate recognition memory [21, 22]. The analysis began with the
experimenter handling the mice 5 min/day for 3 days (days 1–3). On days 4 and 5 the mouse
was placed in the test chamber (32 × 28 × 30 cm) for 20 min for habituation to the chambers.
On day 6 the mouse was placed for 5 min in the test chamber, which now contained two iden-
tical objects selected at random from a collection of 2 sets of identical objects: Two unopened
and unmarked cans of food (3.14 X 3.6 X 11 cm) or two Lego objects (6.4 X 6.4 X 11 CM). The
two sets are needed so that in the next stage of the test, a novel object can be drawn from a set
to which the mouse was not previously exposed (see below). Total time spent exploring the
objects as well as the time spent exploring the object placed on left versus right side was calcu-
lated. These data were used post hoc to evaluate object or side bias. A counter-balanced design
was used to address potential bias.
Next, the mouse was returned to its home cage. Following 10 min in the home cage, the
mouse was returned to the test chamber, which now contained one of the previously explored
objects and a novel object (chosen from the set not used in the previous step). The mouse was
allowed to explore the objects for 5 min. The total time spent exploring both the objects as well
as time spent exploring each object were calculated.
During each stage of the test (except during the 10 min stay in the home cage), the behavior
of the mouse was recorded using an overhead video camera. An investigator blinded to the
identity of the mouse analyzed the video recordings. Based on an exclusion criterion of less
than 30 sec exploration of objects (i.e. <10% of the allotted time) no mouse was eliminated
from the study.
The novel object recognition index was calculated using the formula: time spent with the
novel object on day 6 / the time spent with both the objects on day 6 (novel object + familiar
object) X 100.
Perinatal nicotine exposure mouse model
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Cliff avoidance reflex (CAR)
Impulsive-like behavior was assayed using an apparatus consisting of a custom-built round
Plexiglas platform (20 cm in diameter) supported on a plastic rod (50 cm in height) similar to
a barstool [23]. The mice were placed individually on the platform and their behavior was
recorded via an overhead video camera for a period of 60 minutes. When a mouse fell off the
platform, it was gently picked up and returned to the platform. An investigator blinded to the
identity of the mouse analyzed the video recording to calculate the average length of time to
first fall (latency to first fall) during the 60 min interval.
Number of mice used and the sequence of behavioral tests
Male and female mice from up to 8 litters from each of the three treatment groups (N+S, S and
W) were used in each of the behavioral paradigms. A total of 6 behavioral tests were conducted
in this study with approximately one-week interval between the tests. Using a mouse in every
one of the 6 tests sequentially would have meant that the mouse would have been approxi-
mately 2 months older by the end of test #6 compared to their age during test #1. Moreover,
we were concerned that the experience of undergoing more than 3 behavioral tests consecu-
tively could influence performance in the subsequent behavioral tests. To avoid the potential
influence of these variables, one male and one female mouse from each litter were assigned to
one of two groups. Each group of mice was tested in only one battery of behavioral tests. Thus,
the first group was examined sequentially in spontaneous locomotor activity, EPM and NOR
test, and the second sequentially in Y-maze, OBA test, and CAR test. The NOR test was con-
ducted in male mice only.
Statistical analysis
We confirmed normal distribution of data from all our experiments. Therefore, differences
between experimental groups were analyzed for statistical significance using parametric statis-
tical tests. Two-way ANOVA was used to test the main effects of perinatal treatment and sex,
and the interaction between these two factors. When a significant difference (p<0.05) was
found by ANOVA, Bonferroni multiple comparison post hoc test was used. A one-way
ANOVA was used for analysis of the NOR data as comparisons were made among the three
experimental groups for male mice only. An unpaired Student’s t-test was used whenever dif-
ferences between only two groups were evaluated. Data on bodyweight from P0 to P21 were
analyzed using Repeated Measures ANOVA. In all cases, a p value of< 0.05 was considered to
be statistically significant. Prism 6 Software (GraphPad Software Inc., San Diego, CA) was
used for the statistical analyses.
Results
Body weight, water consumption, length of pregnancy, litter size, and
offspring metrics
There was no significant difference in body weight among the three treatment groups over the
period P0 to P21 [F(2,60) = 0.002, p = 0.99]. However in the case of body weight at P90, there
was a significant main effect of sex [F(1,42) = 770, p<0.0001], and no significant main effect of
treatment [F(2,42) = 0.51, p = 0.60] or interaction between sex and treatment [F(2,42) = 0.05,
p = 0.95]. Bonferroni multiple comparison post hoc test showed that the P90 male mice had sig-
nificantly greater body weight compared to females, regardless of the perinatal treatment [S1
and S2 Tables].
Perinatal nicotine exposure mouse model
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The average length of pregnancy (19–20 days), litter size at birth (6–9), and sex ratio at
birth (1:1) were comparable among the three treatment groups. Drinking water intake by preg-
nant dams in the three treatment groups throughout the experimental period (3 weeks prior to
mating and during pregnancy) was also comparable [Mean ± SEM (ml/day): W: 9.86 ± 0.66; S:
10.59 ± 0.97; N + S: 9.47 ± 0.89]. The following developmental milestones were achieved on
average at the same time by all offspring in the three treatment groups: Ears detached on P4,
fur appeared on P6-7 and eyes opened on days P14-15. The developmental milestones are
comparable to those in our previous studies of prenatal nicotine exposure, in which the off-
spring were cross-fostered to drug naïve dams on the day of birth [8, 15].
Spontaneous locomotor activity
There were no significant main effects of treatment [F(2,44) = 1.09, p = 0.35] or sex [F(1,44) =
3.19, p = 0.08], or interaction between sex and treatment [F(2,44) = 0.85, p = 0.43 [Fig 1; S1
Table].
Elevated plus maze (EPM)
There were no significant main effects of treatment [F(2,27) = 0.06, p = 0.95], sex [F(1,27) =
3.92, p = 0.06], or interaction between sex and treatment [F(2,27) = 0.56, p = 0.58] on time
spent in open arms [Fig 2A, S1 Table]. Similarly, there were no significant main effects of treat-
ment [F(2,27) = 0.06, p = 0.94], sex [F(1,27) = 3.16, p = 0.09], or interaction between sex and
treatment [F(2,27) = 0.02, p = 0.98] on the number of entries into the open arms [Fig 2B, S1
Table].
Fig 3. Perinatal nicotine exposure produces a significant decrease in spontaneous alternation in the Y-maze in male but not female offspring.
Spontaneous alternation in the Y-maze was analyzed in male and female mice from the nicotine+saccharin (N + S), saccharin alone (S) and plain drinking water
(W) groups. There was a significant decreases in this measurement in male mice from the N+S group. p<0.001. [Mean ± SEM: Male: W: 71.31 ± 1.20; S:
71.11 ± 4.33; N + S: 52.37 ± 4.63; Female: W: 65.57 ± 4.43; S: 66.63 ± 4.42; N + S: 67.19 ± 3.56].
https://doi.org/10.1371/journal.pone.0198064.g003
Perinatal nicotine exposure mouse model
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Spatial working memory
There was a significant main effect of treatment [F(2,32) = 5.01, p = 0.01] and interaction
between sex and treatment [F(2,32) = 6.37, p = 0.0047], and no significant main effect of sex [F
(1,32) = 0.34, p = 0.56] on spontaneous alternation in the Y-maze. Bonferroni multiple com-
parison test showed significant decreases in spontaneous alternation in male mice in the N+S
group compared to the male mice in the W or S groups [Fig 3]. None of the other pair-wise
comparisons were significant [S1 and S2 Tables].
Object based attention (OBA)
The recognition index was>50% in male and female mice in the W and S (control) groups
[Fig 4] suggesting a greater than chance performance level in the control groups. However, to
establish that the control groups “recognized” the novel object over the familiar object on Day
6 (test day), we compared time spent exploring the familiar versus the novel object by male and
female mice in the W and S groups. In both the control groups, male and female mice spent
significantly longer time exploring the novel object compared to the familiar object (Male W:
t = 6.41, p = 0.001; Female W: t = 2.35, p = 0.04; Male S: t = 6.93; p = 0.001; Female S: t = 3.06,
p = 0.01) indicating that the mice in the control groups successfully performed the test. Next,
we analyzed the data for all treatment groups. There was a significant main effect of treatment
[F(2,30) = 3.41, p = 0.04] and interaction between sex and treatment [F(2,30) = 3.39, p = 0.04],
and no significant main effect of sex [F(1,30) = 2.35, p = 0.14] in the OBA test. Bonferroni mul-
tiple comparisons test showed significant deficits in OBA in male mice in the N+S group com-
pared to their counterparts in the W and S groups. None of the other pair-wise comparisons
showed significant effects [Fig 4, S1 and S2 Tables].
Fig 4. Perinatal nicotine exposure produces attention deficits in male offspring in the object based attention (OBA) test. Recognition index was analyzed
in male and female mice from the nicotine+saccharin (N + S), saccharin alone (S) and plain drinking water (W) groups. There was a significant decrease in this
measurement in male mice from the N+S group. p<0.05. [Mean ± SEM: Male: W: 73.95 ±4.65; S: 74.93 ± 4.85; N + S: 50.04 ± 4.65; Female: W: 56.01 ± 4.60; S:
62.61 ± 4.80; N + S: 59.46 ± 7.85].
https://doi.org/10.1371/journal.pone.0198064.g004
Perinatal nicotine exposure mouse model
PLOS ONE | https://doi.org/10.1371/journal.pone.0198064 May 24, 2018 9 / 20
Novel object recognition (NOR)
Since only male mice in the N+S group showed significant deficits in the OBA test [Fig 4, S1
and S2 Tables], we used only male mice in the NOR test. Initially, we examined whether the
mice showed left-right bias. A Student’s t -test showed no significant bias toward a side [Mean
±SEM Exploration (sec): Left: 21.3 ± 1.33; Right: 22.39 ± 1.15; t = 0.62, df = 46, p = 0.54], or
toward an object [Mean±SEM Exploration (sec): Un-opened can: 43.15 ± 4.15; Lego:
44.24 ± 2.54; t = 0.22, df = 22, p = 0.82]. Next, we compared time spent exploring the familiar
versus novel object by male mice in the W and S control groups. In both the control groups,
the mice spent significantly longer period of time exploring the novel object compared to the
familiar object (W: t = 3.33, p = 0.01; S: t = 5.77, p = 0.01). Finally, a one-way ANOVA showed
no significant difference among the three treatment groups in the novel object recognition
index [F(2,21) = 0.43, p = 0.65; Fig 5].
Cliff avoidance reflex (CAR)
A two-way ANOVA of the latency to first fall data did not show significant main effects of
treatment [F(2,30) = 0.003, p = 0.99], main effect of sex [F(1,30) = 3.35, p = 0.08], or interaction
between sex and treatment in the CAR assay [F(2,30) = 0.47, p = 0.63] [Fig 6, S1 Table].
Discussion
Our data show that perinatal nicotine exposure beginning 3 weeks prior to conception, con-
tinuing through gestation, and ending at weaning produces significant deficits in spatial work-
ing memory (Y maze) and attention (OBA) at P90 in male offspring but not in female
offspring. The perinatal nicotine exposure did not produce significant changes in spontaneous
locomotor activity, anxiety-like behavior (EPM), impulsive-like behavior (CAR), or
Fig 5. Perinatal nicotine exposure and Novel-object recognition test (NOR). Data combined from the nicotine+saccharin (N + S), saccharin alone (S) and
plain drinking water (W) groups are shown There was no significant difference in the time spent exploring novel versus familiar object (discrimination
index) in male and female mice from the N + S, S and W groups. [Mean ± SEM: Male: W = 69.92 ± 5.26; S = 58.8 ± 1.11; N + S = 58.57 ± 2.11.
https://doi.org/10.1371/journal.pone.0198064.g005
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recognition memory using novel object recognition (NOR) at P90. The nicotine exposure did
not produce significant effects on litter size, offspring birth weight, weight gain during devel-
opment or mature body weight at P90. Exposure to saccharin alone did not influence any of
the parameters.
The deficits in attention and working memory in male mice emerge as the only significant
behavioral deficits produced by the perinatal nicotine exposure in the present study. Interest-
ingly, working memory and attention deficits were also fund in our prenatal nicotine exposure
mouse model [15], and are comorbid conditions in ADHD [24–28]. Therefore, developmental
nicotine exposure mouse models appear to have significant face validity as ADHD experimen-
tal models.
We used the OBA test to evaluate attention in the present study and in our previous study
of prenatal nicotine exposure [15]. The OBA test has been used to assay attention in other
mouse models of developmental nicotine exposure [3, 20]. Although the OBA test incorpo-
rates design features intended to exclude recognition memory as a confounding variable [15,
20], there may be a concern that performance in the OBA test by the N+S group of mice may
be influenced by potential direct effects the nicotine exposure on recognition memory. To
address this potential concern, we measured recognition memory using the NOR test. Consis-
tent with findings from other studies [4], we found that male mice in the N+S group did not
show significant changes in recognition memory compared to the control groups. Therefore,
the attention deficits in the OBA test observed in the male mice (female mice did not show
OBA deficits) are unlikely to be influenced by changes in recognition memory.
Another major finding in the present study is that the deficits in attention and working
memory are sex-specific. Sex differences in nicotine’s effects on the brain and behavior have
been described previously [29–32]. Developmental nicotine exposure produces sex-dependent
changes in hyperactivity, nicotine preference and pre-pulse inhibition [6, 33–36]. A review of
Fig 6. Perinatal nicotine exposure and cliff avoidance reflex (CAR). The latency to first fall over the 60 min interval were analyzed. There was no significant
difference in the latency to first fall [Mean ± SEM (min): Male: W = 50.41 ± 3.83; S = 48.67 ± 5.56; N + S = 44.84 ± 7.78; Female: W = 53.83 ± 2.91;
S = 55.92 ± 3.01; N + S = 58.83 ± 2.08] in male or female mice from the nicotine+saccharin (N + S), saccharin alone (S) and plain drinking water (W) groups.
https://doi.org/10.1371/journal.pone.0198064.g006
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the literature shows that sex differences in hypothalamic-pituitary axis signaling, estrogen
receptor signaling, neurotransmitter receptor signaling, especially dopamine receptor expres-
sion are among the candidate mechanisms proposed for sex differences in the effects of devel-
opmental nicotine exposure [30, 31, 37, 38]. Another potential factor contributing to sex-
dependent effects of developmental nicotine exposure may be nicotine-induced epigenetic
modification of the DNA and histones. Since the nicotine exposure in the present study began
prior to conception, it is possible that nicotine produced epigenetic modification of the DNA
and histones in the placenta and somatic cells of the offspring during pre- and postnatal devel-
opment. Smoking during pregnancy alters DNA methylation in the placenta [39, 40] and
somatic cells of the offspring [41, 42]. In addition, nicotine can have a direct impact on DNA
methylation in somatic cells [43, 44] of the exposed individual. Equally interestingly, develop-
mental exposure to cotinine, a metabolite of nicotine can also produce epigenetic modification
of the DNA [45]. Epigenetic modifications can promote or repress gene expression, and some
of the epigenetic changes can influence sex-specific gene expression. Since there are imprints/
parent-of-origin effects on transcription at over 1300 loci [46, 47] and there are ~350 autoso-
mal genes with sex-specific parent-of origin effects in the mouse brain [46, 47], it is conceiv-
able that the sex-specific effects of developmental nicotine exposure have their origins in sex-
specific gene transcription during development. The role of genetic sex, and organizational
versus activational influences, imprinted genes and mitochondrial DNA [46, 47] in mediating
sex-specific effects of nicotine exposure remain to be elucidated.
It has been suggested that the sex-dependent effects of developmental nicotine exposure on
behavioral parameters may be secondary to nicotine’s sex-specific effects on physical develop-
ment. In one study, prenatal nicotine exposure significantly reduced body weight of the female
offspring during neonatal and pre-pubertal development, whereas the growth retardation in
the male offspring occurred later in the adolescent period [48]. The smaller size of the female
offspring in the early postnatal period could impact mother-infant interactions, and thereby
influence behavioral development selectively in the female offspring. Furthermore, prenatal
nicotine exposure increased anxiety-like behavior at P40 in male but not female offspring [48,
49]. However, in the present study we did not observe significant effects of nicotine on body
weight gain in the offspring.
The lack of attention deficits in female mice in the present study is consistent with findings
from human studies, where the diagnosis of ADHD in boys is nearly twice as frequent as that
in girls, although girls and boys manifest the same symptoms [50].
In the present study, the effects of perinatal nicotine exposure on behavioral parameters are
more “selective” or less “severe” than the effects of prenatal nicotine exposure we had reported
previously [9, 15]. This conclusion seems counterintuitive because the perinatal nicotine expo-
sure involves a longer exposure period and therefore may be expected to produce more
“severe” behavioral outcomes compared to the prenatal exposure. Multiple factors could con-
tribute to these seemingly counterintuitive findings.
Timing of the nicotine exposure vis a vis the stages of brain development is a major factor
in determining the effects on the brain and behavior. For example, nicotine exposure occur-
ring from the 12th day of gestation until birth was reported to produce significant effects on
cognitive and emotional behaviors in contrast to exposure occurring prior to this date, which
was reported to be ineffective [3, 4]. However, in our pre- and perinatal exposure models, the
nicotine exposure began at the same time, prior to conception, suggesting that the length of
the exposure may be an equally significant parameter.
One possibility is that with longer nicotine exposures, the potential for adaptation within
the neural systems is proportionately greater. For example, the nicotinic acetylcholine receptor
signaling mechanisms may respond differently to early versus late onset as well as short versus
Perinatal nicotine exposure mouse model
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long duration of exposures. Expression of nearly all of the nicotinic acetylcholine receptor sub-
types in the brain begins early in the embryonic period and the receptors undergo significant
cell-type and brain region specific remodeling throughout pre- and postnatal development
[51–58]. It is conceivable that the timing of onset and duration of the nicotine exposure impact
receptor signaling differently. In addition, if the nicotine exposure began at prenatal stages and
continued into early postnatal stages of development, the prenatal effects may modify the later
postnatal effects. One possibility relevant to the present data is that the postnatal exposure
somehow “mitigates” the effects of the prenatal exposure such that the combined effects are
less severe than the effects of prenatal or postnatal exposures alone.
Besides the “timing” of the nicotine exposure, cross fostering could have been a variable
between our prenatal and perinatal nicotine exposure models. Cross fostering is utilized in
preclinical models of developmental nicotine exposure to limit the nicotine exposure to prena-
tal period as well as to avoid potential adverse effects of impaired interactions between nico-
tine-exposed dams and their offspring upon the body and brain development of the offspring
Table 1. Summary of the literature on the effects of developmental nicotine exposure on anxiety-like behavior in mice.
Mouse Strain Nicotine Exposure Assay Finding Citation
Swiss Webster Nicotine freebase 0.5 mg/kg; s.c. daily from E0 to
P0
Elevated plus maze in
"weaned" mice. Males
were used
Increased time and increased entries into open arms [30]
C57BL/6J (SLC
Inc., Shizuoka,
Japan)
Nicotine freebase 200 μg/ml in drinking water
containing 2% sucrose from various times during
gestation until various times in the postnatal
period
Light-dark box at
P26-P38. Males and
females were used
Decrease in time spent in lighted box in males exposed
to nicotine from E0-P0 and E14-P0. No effect in
females
[3]
Elevated plus maze at
P26-P38. Males and
females were used
Significant reduction in time spent in open arms in
males exposed to nicotine from E0-P7, E14-P7, E0-P0
and E14-P0. In females similar reduction was found
when they were exposed from E0-P0. No effect on the
number of open arms entries in entries males or females
C57BL/6J Inhalation of cigarette smoke 6 hr/day during
gestation until weaning
Light-dark box at P90.
Males and females were
used
Longer duration in the lighted area [31]
Elevated zero maze at
P90. Males and females
were used
Increased time and increased entries into open arms
only in males
DBA/2J and
C57BL/6J
Nicotine freebase in drinking water 200μg/ml
starting 30 days before mating and continuing
through gestation until weaning
Elevated plus maze on
P24 and P75. Male and
female mice were used
Increased entries into open arms at P75 in DBA/2J
female mice and longer time in closed arms at P75 in
C57Bl/6j male mice
[32]
CD1 Nicotine free base 4 mg/kg s.c. daily in 2 doses
from E0 to P0
Elevated plus maze at
P180. Females were used
No change in time spent in open versus closed arms
Elevated platform test at
P180. Females were used
Increased time on platform (increased anxiety-like
behavior)
[34]
Suok test at P180. females
were used
Decreased sensorimotor integration (greater number of
missteps); increased anxiety
C57BL/6J E-cigarette vapor containing 2.4% nicotine 20
min/day from E15-19 and again from P2-16
Light-dark box at P98.
Males were used
Longer duration and number of entries in the lighted
area
[33]
Elevated zero maze at
P98. Males were used
No effect on time spent in open versus closed arms and
increased number of head dips in open arms
https://doi.org/10.1371/journal.pone.0198064.t001
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[6–9, 15, 49, 59]. Only one previous study [49] directly examined the impact of cross fostering
in a rat model of prenatal nicotine exposure, and found that cross fostering had significant
impact on open field exploratory activity and elevated plus maze but not on learning and
memory. In our prenatal nicotine exposure paradigm [8, 9, 15], although we used cross foster-
ing, mice in the nicotine-exposed group as well as the controls groups were cross fostered, in
an attempt to control for the effects of cross fostering. However, our experimental design
could not have addressed any differential between the impacts of cross fostering on the control
versus the nicotine-exposed groups.
Cross fostering introduces sudden withdrawal from nicotine as a variable, as the supply of
nicotine from the nursing mothers’ milk becomes abruptly curtailed upon cross fostering to a
non-nicotine exposed dam. Nicotine withdrawal becomes a variable in virtually every preclini-
cal model of prenatal nicotine exposure because even when the offspring are not cross fostered,
access to nicotine is abruptly terminated at the time of weaning. One study used a gradual
step-up and step-down method of nicotine exposure [60] to avoid the impact of abrupt nico-
tine exposure and withdrawal. However, the effects of abrupt versus gradual withdrawal on the
developing brain or behavioral phenotypes were not compared in the study.
Another behavioral phenotype observed in our prenatal nicotine exposure model and not
present in the present model is CAR, a measure of impulsivity [23]. We found that although
the prenatally nicotine exposed male mice showed significant impairment in CAR [15], neither
male nor female mice showed significant changes in the present study. Impulsive decision
making behavior without regard to the “value” of the reward [44] and decreased pre-pulse
inhibition [36] has been reported in rat models of developmental nicotine exposure.
Although the Discussion above focused primarily on the differences between the findings
from our prenatal versus perinatal nicotine exposure paradigms, a review of the literature
underscores the variability in behavioral outcomes from different mouse models of pre- or
perinatal nicotine exposures [Tables 1 and 2]. Although the precise mechanisms that could
contribute to the differences remain a topic of discussion, a variety of experimental variables
emerge as potential contributors to the differences. These variables include the mouse strain
used (C56Bl/6, SW, DAB), type of nicotine used (freebase, tartrate, hydrochloride), route of
administration (via drinking water, subcutaneous infusion pump, intraperitoneal, intravenous
self-administration), age at which the behavior was examined (20 to 180 days of age), and the
behavioral methodologies used [Tables 1 and 2]. The following discussion may serve to place
the differences between our pre- and perinatal nicotine exposure models within this broader
context.
We will use as examples two commonly evaluated behavioral phenotypes namely, anxiety-
like behavior and locomotor activity to compare the findings from the different experimental
paradigms. Anxiety-like behavior has been analyzed using open field exploration, EPM, ele-
vated zero maze or light-dark box. The findings from some of these studies [Table 1] show
increased time spent in the open arms or lighted areas, suggesting a more exploratory and less
anxious phenotype [61–64], and the others show the opposite [4, 63, 65]. Locomotor activity
was analyzed using continuous measurements of motor activity in a novel environment
(open-field or a rodent cage) for 30 min to 2 hr, or continuous measurements of activity over
20–24 hr in the home cage or a novel cage [Table 2]. In other cases, number of entries into
open or closed arms of the EPM or the arms of a Y maze was also used as a measure of locomo-
tor activity [Table 1]. Overall, some studies reported increased locomotor activity [6, 60–63,
66, 67], whereas others reported decreased activity [62, 63] or no significant change [68]. The
most significant biological variables in the studies compiled in Tables 1 and 2 may be the tim-
ing of the nicotine exposure with respect to the stage of brain development [16–19], and the
mouse strain used.
Perinatal nicotine exposure mouse model
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In conclusion, deficits in working memory and attention in male mice remain the consis-
tent findings in our present study of perinatal nicotine exposure and our previous study of pre-
natal nicotine exposure. Although these two cognitive parameters are not among the most
commonly evaluated parameters in preclinical models of developmental nicotine exposure in
the literature, the reports that did evaluate these parameters have found deficits in both pheno-
types. Since working memory and attention deficits are found in ADHD, we suggest that pre-
clinical rodent models of developmental nicotine exposure can serve as useful models of
behaviors associated with ADHD. Finally, a review of the behavioral findings in the literature
from preclinical models of developmental nicotine exposure shows that experimental design
variations can contribute significantly to the direction and magnitude of the behavioral
outcomes.
Table 2. Summary of the literature on the effects of developmental nicotine exposure on locomotor activity in mice.
Mouse
Strain
Nicotine Exposure Assay Finding Citation
Swiss
Webster
Nicotine freebase 0.5 mg/kg; s.c. daily from E0 to P0 Locomotor Activity in open field at P31.
Male mice were used
Hyperactivity [61]
C57BL/6J Inhalation of cigarette smoke 6 hr/day during
gestation until weaning
Locomotor Activity in open field on P90.
Male and female mice were used
Hyperactivity in the initial 5 min and
Hypo-activity at later times
[62]
DBA/2J and
C57BL/6J
Nicotine freebase in drinking water 200μg/ml starting
30 days before mating and continuing through
gestation until weaning
Locomotor Activity in open field on P24
and P75. Male and female mice were used
Hyperactivity in DBA/2J at P24 and P75
and in C57BL/6J mice at P24. Hypo-
activity in C57BL/6J females at P75
[63]
Swiss
Webster
Nicotine hydrogen tartrate (200μg/ml) in drinking
water containing 2% saccharin starting 2 weeks
before mating and continuing through gestation until
weaning
Locomotor Activity in open field at 3–10
weeks of age. Male mice were used
No effect [68]
C57BL/6J Nicotine hydrogen tartrate (200μg/ml) in drinking
water containing 2% saccharin through gestation
until weaning
Locomotor Activity in open field on P31-
32. Male and female mice were used
Increased locomotor response to novel
environment but no effect later
[66]
C57BL/6J Nicotine freebase 200μg/ml in drinking water
containing 2% saccharin starting 30 days before
mating and continuing through gestation
Locomotor Activity in open field on P20,
P40, and P60. Male and female mice were
used
Females were hypoactive on P20. Males
were hyperactive on P40 and P60
[6]
C57BL/6J Nicotine hydrogen tartrate 0.05 mg/ml drinking
water containing 0.066% saccharin starting 2 weeks
prior to conception and continuing through gestation
and until weaning
Locomotor Activity in open field from
P60-P100. Male and female mice were
used
Hyperactivity [60]
C57BL/6J
(NCI)
E-cigarette vapor containing 2.4% nicotine 20 min/
day from E15-20 and again from P2-16
Locomotor Activity in open field at P98.
Male mice were used
Hyperactivity [64]
B6C3F1 Inhalation of cigarette smoke 4 h/d and 5 d/week
from E4 until E18
Locomotor Activity in open field at P28
and P120. Males and females were used
Hyperactivity in both sexes at P28, and
only in males at P120
[67]
C57BL/6 Nicotine freebase 200 μg/ml in drinking water
containing 2% saccharin beginning 3 weeks before
conception and continuing until P0
Spontaneous locomotor activity in non-
home cage measured continuously over 20
hr in P42-P60 male and female mice.
Hyperactivity in males and females [9]
https://doi.org/10.1371/journal.pone.0198064.t002
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